Headlands Technologies LLC Buys New Position in Addus HomeCare Corporation $ADUS

Headlands Technologies LLC bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,841 shares of the company’s stock, valued at approximately $687,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Leeward Investments LLC MA boosted its position in Addus HomeCare by 9.4% during the first quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock valued at $11,318,000 after acquiring an additional 10,414 shares during the last quarter. Summit Creek Advisors LLC acquired a new stake in Addus HomeCare in the second quarter worth $8,552,000. Bank of America Corp DE increased its position in Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after buying an additional 32,714 shares in the last quarter. Vanguard Group Inc. increased its position in Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after buying an additional 10,501 shares in the last quarter. Finally, TimesSquare Capital Management LLC bought a new stake in Addus HomeCare in the 2nd quarter valued at about $31,502,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $118.17 on Thursday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The business has a 50 day moving average price of $113.14 and a 200-day moving average price of $103.06. The company has a market cap of $2.21 billion, a PE ratio of 20.73, a price-to-earnings-growth ratio of 1.54 and a beta of 0.86.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.Addus HomeCare’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.49 earnings per share. Equities analysts anticipate that Addus HomeCare Corporation will post 6.3 earnings per share for the current fiscal year.

Analyst Ratings Changes

ADUS has been the subject of several recent research reports. Barclays boosted their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Royal Bank Of Canada boosted their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Citizens Jmp restated a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $128.86.

Insider Activity

In other news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.